It won't surprise me if we see further Change of Directors Notices in the near future. Given the growth prospects of the company and it's significant cash balance, the current share price represents very good value.
The Veritas analysis available in the investors section of the Orthocell website lays it all out pretty clearly. They predict revenue doubling each year through FY24, FY25, FY26. Recommended reading for anyone who hasn't had a look yet.
It won't surprise me if we see further Change of Directors...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $77.45M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 37.0¢ | $53.87K | 145.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 86513 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 37044 | 2 |
View Market Depth
| Last trade - 14.00pm 24/06/2024 (20 minute delay) ? |
| OCC (ASX) Chart |